By vgreene, 18 November, 2019 pembrolizumab for MSI H or dMMR 8 14 pembrolizumab 200 mg IV x1 Cycled q21 days for up to 24mo
By vgreene, 18 November, 2019 docetaxel prednisone rechallenge 9 10Day 1 docetaxel 75 mg m2 dose IV x1 Cycled q21 days for up to 10 cycles prednisone 5 mg PO bid continuously
By vgreene, 18 November, 2019 cabazitaxel prednisone6 8 Day 1 cabazitaxel 20 25 mg m2 dose IV x1 Cycled q21 days prednisone 10 mg PO qd continuously
By vgreene, 18 November, 2019 abiraterone acetate prednisone2 4abiraterone 1000 mg PO qd prednisone 5 mg PO bid
By vgreene, 18 November, 2019 If prior docetaxel tx,1 continue ADT (androgen deprivation therapy) + 1 of the following:
By vgreene, 18 November, 2019 pembrolizumab (for MSI-H or dMMR)12 pembrolizumab 200 mg IV x1Cycled q21 days for up to 24mo
By vgreene, 18 November, 2019 sipuleucel-T (if not previously received, if no or minimal sx, no liver metastases, life expectancy >6mo, and an ECOG score of 0–1)11 Day 1: sipuleucel-T dose (≥50 million autologous CD54+ cells) IV x1Cycled q14 days x3 cycles